Skip Navigation



Glycobiology Advance Access published online on January 10, 2007
Glycobiology, doi:10.1093/glycob/cwl082
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
17/4/374    most recent
cwl082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wandall, H. H.
Right arrow Articles by Clausen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wandall, H. H.
Right arrow Articles by Clausen, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate binding specificity for GalNAc: Lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.

Hans H. Wandall1,2, Fernando Irazoqui1,3, Mads Agervig Tarp1, Eric P. Bennett1, Ulla Mandel1, Hideyuki Takeuchi4, Kentaro Kato1, Tatsuro Irimura4, Ganesh Suryanarayanan5, Michael A. Hollingsworth5 and Henrik Clausen1,

1 Department of Medical Biochemistry and Genetics and the Department of Oral Diagnostics, Dental School, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark
3 CIQUIBIC-CONICET / Department of Biological Chemistry, Faculty of Chemical Sciences, National University of Cordoba, 5000 Cordoba, Argentina
4 Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
5 Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198

Address correspondence to: Henrik Clausen, Department of Medical Biochemistry and Genetics, the Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark. Tel.: +45 35327797, Fax: +45 35367980, E-mail: hc{at}imbg.ku.dk

Received on August 9, 2006; revised on November 21, 2006; accepted on December 19, 2006

Initiation of mucin-type O-glycosylation is controlled by a large family of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (GalNAc-transferases). Most GalNAc-transferases contain a ricin-like lectin domain in the C-terminal end, which may confer GalNAc-glycopeptide substrate specificity to the enzyme. We have previously shown that the lectin domain of GalNAc-T4 modulates its substrate specificity to enable unique GalNAc-glycopeptide specificities and that this effect is selectively inhibitable by GalNAc; however, direct evidence of carbohydrate binding of GalNAc-transferase lectins has not been previously presented. Here we report the direct carbohydrate binding of two GalNAc-transferases, GalNAc-T4 and GalNAc-T2, and their isolated lectins domains, representing isoforms reported to have distinct glycopeptide activity (GalNAc-T4) and isoforms without apparent distinct GalNAc-glycopeptide specificity (GalNAc-T2). Both lectins exhibited specificity for binding of free GalNAc. Kinetic and time-course analysis of GalNAc-T2 demonstrated that the lectin domain did not affect transfer to initial glycosylation sites, but selectively modulated velocity of transfer to subsequent sites and affected the number of acceptor sites utilized. The results suggest that GalNActransferase lectins serve to modulate the kinetic properties of the enzymes in the late stages of the initiation process of O-glycosylation to accomplish dense or complete O-glycan occupancy.

Key words: GalNAc / transferases / lectins / glycans / mucins

2 Present address: Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Raman, T. A. Fritz, T. A. Gerken, O. Jamison, D. Live, M. Liu, and L. A. Tabak
The Catalytic and Lectin Domains of UDP-GalNAc:Polypeptide {alpha}-N-Acetylgalactosaminyltransferase Function in Concert to Direct Glycosylation Site Selection
J. Biol. Chem., August 22, 2008; 283(34): 22942 - 22951.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
P. Herr, G. Korniychuk, Y. Yamamoto, K. Grubisic, and M. Oelgeschlager
Regulation of TGF-{beta} signalling by N-acetylgalactosaminyltransferase-like 1
Development, May 15, 2008; 135(10): 1813 - 1822.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Napoletano, A. Rughetti, M. P. Agervig Tarp, J. Coleman, E. P. Bennett, G. Picco, P. Sale, K. Denda-Nagai, T. Irimura, U. Mandel, et al.
Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells
Cancer Res., September 1, 2007; 67(17): 8358 - 8367.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.